Table 1.
In vitro neutralization potency |
|||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Affinity (MSD Fab KD, pM) |
IC50 expressed as mAb: toxin ratio |
||||||||||||
Hla | HlgB | LukF | LukD | Hla |
Hla |
HlgCB |
HlgAB |
LukSF |
LukED |
HlgA-LukD |
Hla LukSF HlgCB HlgAB LukED |
Hla LukSF HlgCB HlgAB LukED |
|
mAbs | rRBC | A549 | hPMN | hRBC | hPMN | hPMN | hRBC | hPMN | hRBC | ||||
Hla-F#1 | 2.9a | 5.1 | 120 | 2200 | <0.25 | <0.5 | 1.2 | 13.5 | 7.8 | 4.9 | 8.2 | 3.5 | 2.9 |
Hla-F#2 | 37a | 18 | < 3 | 1700 | <0.25 | 0.6 | 0.7 | 6.5 | 0.5 | 4.8 | 7.3 | 1.1 | 1.6 |
Hla-F#3 | 23a | 140 | nd | 86 | <0.25 | <0.5 | 147.6 | nd | nd | 0.3 | 1.2 | nd | nd |
Hla-F#4 | 30a | 160 | nd | 160 | <0.25 | <0.5 | 180.7 | nd | nd | 0.4 | 1.4 | nd | nd |
Hla-F#5 | <2a, 2.1b | < 3 | < 3 | 400 | < 0.25 | < 0.5 | 0.7 | 5.6 | 0.7 | 1.0 | 3.0 | 0.5 | 1.1 |
Hla-F#6 | < 2a | < 2 | 50 | 290 | < 0.25 | < 0.5 | 0.8 | 2.8 | 2.2 | 0.9 | 2.3 | 0.8 | 0.6 |
Hla-F#7 | < 2a | < 2 | 73 | 780 | < 0.25 | < 0.5 | 0.3 | 4.2 | 2.7 | 2.2 | 4.8 | 1.2 | 0.9 |
Hla | 40b | nd | nd | nd | < 0.25 | < 0.5 | nd | nd | nd | nd | nd | nd | nd |
HlgB | nd | 4.2 | nd | nd | nd | nd | 1.6 | 1.6 | nd | nd | nd | nd | nd |
LukD | nd | nd | nd | 7.0 | nd | nd | nd | nd | nd | 0.2 | 1.2 | nd | nd |
LukF | nd | nd | 9000 | nd | nd | nd | nd | nd | 93.4 | nd | nd | nd | nd |
243-4 | 13b | nd | nd | nd | < 0.25 | < 0.5 | nd | nd | nd | nd | nd | nd | nd |
LC10 | 13b | nd | nd | nd | < 0.25 | < 0.5 | nd | nd | nd | nd | nd | nd | nd |
LTM14 | 4.5b | nd | nd | nd | < 0.25 | < 0.5 | nd | nd | nd | nd | nd | nd | nd |
nd: not detectable
a KD values of yeast produced mAbs measured in the same assay (fitted antigen concentrations between 20 and 30 nM were used to calculate lower KD limits (10% of the antigen concentration); b KD values of mammalian cell produced mAbs measured in the same assay at 20 pM antigen concentration (KD limit ∼ 2 pM). 95% confidence intervals of the predicted KDs are typically within two fold or less from the fitted KD values reported here.